CAS 357166-29-1
:N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate
Description:
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate, with CAS number 357166-29-1, is a complex organic compound characterized by its unique structural features, which include a pyrrolopyrimidine moiety and a glutamic acid derivative. This compound typically exhibits properties such as solubility in water due to its disodium salt form, which enhances its bioavailability. It may possess biological activity, potentially acting as an inhibitor or modulator in various biochemical pathways, making it of interest in pharmaceutical research. The presence of amino and carboxyl functional groups suggests it can participate in hydrogen bonding, influencing its interactions in biological systems. Additionally, the hydrate form indicates the presence of water molecules in its crystalline structure, which can affect its stability and solubility. Overall, this compound's intricate structure and functional groups contribute to its potential applications in medicinal chemistry and drug development.
Formula:C20H19N5Na2O6・7(H2O)
Synonyms:- Pemetrexed disodium hepthydrate
- Pemetrexed disodium heptahydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
PEMETREXED DISODIUM HEPTAHYDRATE CRS
CAS:PEMETREXED DISODIUM HEPTAHYDRATE CRSFormula:C20H19N5Na2O6Molecular weight:471.3743PEMETREXED FOR SYSTEM SUITABILITY CRS
CAS:PEMETREXED FOR SYSTEM SUITABILITY CRSFormula:C20H19N5Na2O6Molecular weight:471.3743Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C20H19N5Na2O6·7H2OColor and Shape:White PowderMolecular weight:597.18702L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate
CAS:Formula:C20H33N5Na2O13Purity:98%Color and Shape:SolidMolecular weight:597.4813Pemetrexed disodium heptahydrate
CAS:Pemetrexed disodium heptahydrateFormula:C20H19N5O6·2Na·7H2OPurity:99%Color and Shape: white solidMolecular weight:597.48g/molPemetrexed disodium heptahydrate
CAS:Pemetrexed disodium heptahydrate (LY231514) is an antifolate that inhibits TS, DHFR and GARFT, inhibits precursor purine and pyrimidine nucleotides.Formula:C20H33N5Na2O13Purity:99.783%Color and Shape:SolidMolecular weight:597.49Pemetrexed Disodium Heptahydrate
CAS:Controlled ProductFormula:C20H19N5O6NaH2OColor and Shape:NeatMolecular weight:597.48Pemetrexed, Disodium Salt, Heptahydrate
CAS:Formula:C20H19N5Na2O6Color and Shape:SolidMolecular weight:471.381Pemetrexed Disodium Heptahydrate
CAS:Controlled Product<p>Applications Pemetrexed Disodium Heptahydrate is an chemotherapy drug for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed Disodium Heptahydrate exhibit inhibitory activities towards thymidylate synthase as well as other folate dependent enzymes.<br>References Vogelzang, N.J., et al.: J. Clin. Oncol., 21,2636 (2003); Paz-Ares, L., et al.: Lancet. Oncol., 13, 247 (2012);<br></p>Formula:C20H19N5O6·2Na·7H2OColor and Shape:NeatMolecular weight:597.48









